0001420506-17-000048.txt : 20170127 0001420506-17-000048.hdr.sgml : 20170127 20170127114627 ACCESSION NUMBER: 0001420506-17-000048 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170127 DATE AS OF CHANGE: 20170127 EFFECTIVENESS DATE: 20170127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC CENTRAL INDEX KEY: 0001020455 IRS NUMBER: 133087622 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05883 FILM NUMBER: 17552489 BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127516677 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: RHO MANAGEMENT CO INC DATE OF NAME CHANGE: 19960806 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001020455 XXXXXXXX 12-31-2016 12-31-2016 false RHO CAPITAL PARTNERS INC
152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019
13F HOLDINGS REPORT 028-05883 N
Peter E. Kalkanis Chief Financial Officer 2127516677 Peter E. Kalkanis, Chief Financial Officer NEW YORK NY 01-25-2017 0 5 130522 false
INFORMATION TABLE 2 Form13F_InfoTable.xml INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC CARA THERAPEUTICS INC COM 140755109 28502 3068057 SH SOLE 3068057 0 0 INOTEK PHARMACEUTICALS CORP COM 45780V102 16030 2627790 SH SOLE 2627790 0 0 INTRALINKS HLDGS INC COM 46118H104 85048 6290503 SH SOLE 6290503 0 0 RUBICON PROJ INC COM 78112V102 380 51231 SH SOLE 51231 0 0 SENSEONICS HLDGS INC COM 81727U105 562 210342 SH SOLE 210342 0 0